Veterinary Emergency & Critical Care Society (VECCS)’s Post

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Next in our IV complication series: Phlebitis! Watch the video below to understand the implications of phlebitis for patients, and what happens inside the vein when there is movement on the IV line. #IVcomplications #patientcare #SafeBreakVascular #LineusMedical

☃️ On the 1st day of #Photonmas, we celebrate having reached 🌟 1 million 🌟 prescriptions routed. We like to see it as 1 million opportunities for Photon to help patients fulfill their medications with greater ease and transparency (or perhaps: 1 million headaches saved 😄). Stay tuned as we count the days of #Photonmas and celebrate an eventful year. #DigitalHealth #HealthcareStartup #PharmacyInnovation #PatientExperience

In patients with well-differentiated grade 2 and 3 GEP NETs, dual-tracer (⁶⁸Ga-DOTATATE and ¹⁸F-FDG) PET frequently impacts patient management. https://ow.ly/iB7p50TrUMq #NuclearMedicine #NeuroendocrineTumor #PETscan

As we recognize #BreastCancerAwareness Month, let's not forget the critical role #pharmacists play in patient care—offering guidance on early #detection, #managing #treatment side effects, and ensuring therapy adherence. Pharmacists are key in supporting #patients throughout their #breastcancer journey. Together, we can raise awareness, support ongoing research, and improve patient outcomes. #BreastCancerAwareness #PharmacistsCare #EarlyDetectionSavesLives #WomensHealth

Keeping rancid materials out of the feeding lumen while cleaning the ENFit connector is essential. #patientsafety, #Enfit, #gedsa, #oley, #enclean